These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18687456)

  • 21. Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in south-western Uganda.
    Hart GJ; Pool R; Green G; Harrison S; Nyanzi S; Whitworth JA
    AIDS Care; 1999 Dec; 11(6):687-98. PubMed ID: 10716009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translation of biomedical prevention strategies for HIV: prospects and pitfalls.
    Vermund SH; Tique JA; Cassell HM; Pask ME; Ciampa PJ; Audet CM
    J Acquir Immune Defic Syndr; 2013 Jun; 63 Suppl 1(0 1):S12-25. PubMed ID: 23673881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive Services.
    Chin HB; Sipe TA; Elder R; Mercer SL; Chattopadhyay SK; Jacob V; Wethington HR; Kirby D; Elliston DB; Griffith M; Chuke SO; Briss SC; Ericksen I; Galbraith JS; Herbst JH; Johnson RL; Kraft JM; Noar SM; Romero LM; Santelli J;
    Am J Prev Med; 2012 Mar; 42(3):272-94. PubMed ID: 22341164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring the effectiveness of targeted interventions.
    Hassig S
    Netw Res Triangle Park N C; 1991 Jun; 12(1):21-3. PubMed ID: 12316889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions.
    Chersich MF; Rees HV
    AIDS; 2008 Dec; 22 Suppl 4():S27-40. PubMed ID: 19033753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV prevention: Making male circumcision the 'right' tool for the job.
    Bell K
    Glob Public Health; 2015; 10(5-6):552-72. PubMed ID: 24720343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can antiretroviral therapy eliminate HIV transmission?
    De Cock KM; Gilks CF; Lo YR; Guerma T
    Lancet; 2009 Jan; 373(9657):7-9. PubMed ID: 19038440
    [No Abstract]   [Full Text] [Related]  

  • 28. Biomedical HIV prevention--and social science.
    Imrie J; Elford J; Kippax S; Hart GJ
    Lancet; 2007 Jul; 370(9581):10-1. PubMed ID: 17617254
    [No Abstract]   [Full Text] [Related]  

  • 29. Perspectives on HIV prevention: priorities for a new era.
    Warren MJ; Bass ES
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2():S255-9. PubMed ID: 23764644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV research in South Africa: Advancing life.
    Gray G; Doherty T; Mohapi L; Coetzee J; Hopkins KL; Malahleha M; Lazarus E; Dietrich J; Pillay-van Wyk V; Laher F
    S Afr Med J; 2019 Dec; 109(11b):36-40. PubMed ID: 32252866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions.
    Koblin BA; Andrasik M; Austin J
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S183-6. PubMed ID: 23764634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies.
    Buchbinder S
    Top HIV Med; 2008; 16(1):9-14. PubMed ID: 18441378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of the quality of trials evaluating biomedical HIV prevention interventions shows that many lack power.
    Graham SM; Shah PS; Aesch ZC; Beyene J; Bayoumi AM
    HIV Clin Trials; 2009; 10(6):413-31. PubMed ID: 20133272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination HIV prevention: significance, challenges, and opportunities.
    Kurth AE; Celum C; Baeten JM; Vermund SH; Wasserheit JN
    Curr HIV/AIDS Rep; 2011 Mar; 8(1):62-72. PubMed ID: 20941553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community consensus statement on the use of antiretroviral therapy in preventing HIV transmission.
    Nam And European Aids Treatment Group
    Reprod Health Matters; 2014 May; 22(43):191-6. PubMed ID: 24908472
    [No Abstract]   [Full Text] [Related]  

  • 36. Overview of effective and promising interventions to prevent HIV infection.
    Auerbach JD; Hayes RJ; Kandathil SM
    World Health Organ Tech Rep Ser; 2006; 938():43-78; discussion 317-41. PubMed ID: 16921917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HIV 2012 : research update].
    Behrens GM
    Internist (Berl); 2012 Oct; 53(10):1187-94. PubMed ID: 22961071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating behavioral and biomedical research in HIV interventions: challenges and opportunities.
    Rausch DM; Grossman CI; Erbelding EJ
    J Acquir Immune Defic Syndr; 2013 Jun; 63 Suppl 1():S6-11. PubMed ID: 23673890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: balancing methodological rigor and research ethics.
    Underhill K
    Soc Sci Med; 2013 Oct; 94():115-23. PubMed ID: 23597916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social and behavioural research prospects for sexually transmissible infection prevention in the era of advances in biomedical approaches.
    Hogben M; Dittus PJ; Leichliter JS; Aral SO
    Sex Health; 2020 Apr; 17(2):103-113. PubMed ID: 32119815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.